Prospective evaluation of high-cost management of severe chronic ITP in children and adolescents <16 years

Pediatric Blood and Cancer

Volumn 47, Issue 5 SUPPL., 2006, Pages 731-733

  El Alfy, M S ^a   Khalifa, A S ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Cost; Prospective and chronic ITP

Indexed keywords

ANTIFIBRINOLYTIC AGENT; HORMONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; RHESUS D ANTIBODY; STEROID;

ABSENCE OF SIDE EFFECTS; ADOLESCENCE; ADOLESCENT; ASEPTIC MENINGITIS; BLEEDING; CHILD; CHILDHOOD; CHRONICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DRUG COST; FOLLOW UP; HEALTH CARE COST; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVASCULAR HEMOLYSIS; MAJOR CLINICAL STUDY; MENORRHAGIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

ADOLESCENT; CHILD; CHRONIC DISEASE; COST OF ILLNESS; DISEASE MANAGEMENT; DRUG ADMINISTRATION SCHEDULE; EGYPT; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; PLATELET COUNT; PREDNISOLONE; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33748488243     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21007     Document Type: Review

References (12)

1. Imbach P, Kuhne T, Muller D, et al. Childhood ITP: 12 months follow-up data from the prospective registry 1 of International Childhood ITP study group (ICIS). Pediatr Blood Cancer 2006;46:351-356.
2. Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002;141:683-688.
3. Childhood ITP Study Group (ICIS). State of the art expert Intercontinental meeting on ITP, Burgenstock, Switzerland. J Pediatr Hematol Oncol 2003;25:XX-XX.
4. Bolton-Maggs PH. Severe bleeding in idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 2003;25:XX-XX.
5. Lilleyman JS. Intracranial hemorrhage in idiopathic thrombocytopenic purpura. Arch Dis Child 1994;71:251-253.
6. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and long term outcome. J Pediatr 1998;133:334-339.
7. El Alfy MS, Mokhtar GM, El Labodoudy MA, et al. Randomized trial of anti D immunoglobulin versus low dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura. Acta Hematologica 2006;115:46-52.
8. Borgna Pignatti C, Rugolotto S, Nobili B, et al. A trial of high dose dexamethasone therapy for chronic idiopathic thrombocytopenic purpura in childhood. J Pediatr 1997;130:13-16.
9. Kuhne T, Freedman J, Semple JW, et al. Platelet and immune responses to oral cyclic dexamethasone therapy in childhood chronic immune thrombocytopenic purpura. J Pediatr 1997;130:17-27.
10. Blanchette V. Childhood chronic thrombocytopenic purpura: Unresolved issues. J Pediatr Hematol Oncol 2003;25:XX-XX.
11. Bussel J. Novel approaches to the management of immune thrombocytopenic purpura: Results of recent trials. 43rd annual meeting of ASH, Orlando December 7-11, 2001. pp 288-300.
12. George N, Woolf SH, Rakob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.